JP2022550734A5 - - Google Patents
Info
- Publication number
- JP2022550734A5 JP2022550734A5 JP2022519057A JP2022519057A JP2022550734A5 JP 2022550734 A5 JP2022550734 A5 JP 2022550734A5 JP 2022519057 A JP2022519057 A JP 2022519057A JP 2022519057 A JP2022519057 A JP 2022519057A JP 2022550734 A5 JP2022550734 A5 JP 2022550734A5
- Authority
- JP
- Japan
- Prior art keywords
- svhd
- patient
- patients
- vat
- udenafil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025063654A JP2025118624A (ja) | 2019-09-24 | 2025-04-08 | ウデナフィル組成物を用いた単心室心疾患における運動能力、単心室性能、および心筋性能指数（ｍｐｉ）を改善する方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962905350P | 2019-09-24 | 2019-09-24 | |
| US62/905,350 | 2019-09-24 | ||
| US201962936497P | 2019-11-16 | 2019-11-16 | |
| US62/936,497 | 2019-11-16 | ||
| US202063023070P | 2020-05-11 | 2020-05-11 | |
| US63/023,070 | 2020-05-11 | ||
| PCT/US2020/032493 WO2021061203A1 (en) | 2019-09-24 | 2020-05-12 | Methods of improving exercise performance, single ventricular performance, and myocardial performance index (mpi) in single ventricle heart disease, using udenafil compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025063654A Division JP2025118624A (ja) | 2019-09-24 | 2025-04-08 | ウデナフィル組成物を用いた単心室心疾患における運動能力、単心室性能、および心筋性能指数（ｍｐｉ）を改善する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022550734A JP2022550734A (ja) | 2022-12-05 |
| JP2022550734A5 true JP2022550734A5 (https=) | 2023-06-07 |
Family
ID=75167062
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519057A Pending JP2022550734A (ja) | 2019-09-24 | 2020-05-12 | ウデナフィル組成物を用いた単心室心疾患における運動能力、単心室性能、および心筋性能指数（ｍｐｉ）を改善する方法 |
| JP2025063654A Pending JP2025118624A (ja) | 2019-09-24 | 2025-04-08 | ウデナフィル組成物を用いた単心室心疾患における運動能力、単心室性能、および心筋性能指数（ｍｐｉ）を改善する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025063654A Pending JP2025118624A (ja) | 2019-09-24 | 2025-04-08 | ウデナフィル組成物を用いた単心室心疾患における運動能力、単心室性能、および心筋性能指数（ｍｐｉ）を改善する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12576081B2 (https=) |
| EP (1) | EP4041242A4 (https=) |
| JP (2) | JP2022550734A (https=) |
| AU (1) | AU2020356193A1 (https=) |
| CA (1) | CA3155861A1 (https=) |
| MX (1) | MX2022003593A (https=) |
| WO (1) | WO2021061203A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3227475A1 (en) * | 2021-07-26 | 2023-02-02 | Longeveron Inc. | Use of mesenchymal stem cells in treatment of juvenile hypoplastic left heart syndrome |
| CN119072312A (zh) * | 2021-12-20 | 2024-12-03 | 美智恩制药公司 | 用于改善运动表现的方法和组合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050272741A1 (en) * | 2004-01-16 | 2005-12-08 | Jack Rychik | Novel methods of treatment for Fontan patients with protein losing enteropathy |
| US7811244B2 (en) * | 2004-03-23 | 2010-10-12 | Georgia Tech Research Corp. | Anatomical connection |
| PT1888074E (pt) | 2005-06-10 | 2012-03-01 | Dong A Pharm Co Ltd | Agente para a prevenção e tratamento de doenças do fígado contendo um derivado de pirazolopirimidina |
| JP2009509984A (ja) | 2005-09-29 | 2009-03-12 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 泌尿器系障害の処置用のｐｄｅ阻害剤およびそれらの組合せ |
| NL2000291C2 (nl) | 2005-11-10 | 2009-02-17 | Pfizer Prod Inc | 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan. |
| KR100792126B1 (ko) | 2006-04-04 | 2008-01-04 | 동아제약주식회사 | 피라졸로피리미디논 화합물을 유효성분으로 함유하는전립선 비대증 예방 및 치료제 |
| KR101002490B1 (ko) | 2007-06-09 | 2010-12-17 | 동아제약주식회사 | 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물 |
| WO2008151734A1 (en) | 2007-06-13 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | Pde inhibitors for the treatment of hearing impairment |
| KR101004205B1 (ko) | 2008-12-17 | 2010-12-24 | 동아제약주식회사 | 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물 |
| KR101071877B1 (ko) | 2009-02-18 | 2011-10-10 | 동아제약주식회사 | 유데나필 산부가염, 그의 제조방법 및 이를 포함하는 약학적 조성물 |
| CA2784788A1 (en) | 2009-12-18 | 2011-06-23 | Exodos Life Sciences Limited Partnership | Methods and compositions for treating peripheral vascular disease |
| JP2013523809A (ja) | 2010-04-05 | 2013-06-17 | エスケー ケミカルズ カンパニー リミテッド | Ｐｄｅ５抑制剤を含む皮膚しわ改善用組成物 |
| JP5883687B2 (ja) | 2011-03-09 | 2016-03-15 | 第一三共ヘルスケア株式会社 | Ｐｄｅ５阻害剤含有医薬組成物 |
| KR101383430B1 (ko) | 2012-01-26 | 2014-04-08 | 광동제약 주식회사 | 새로운 조합의 구강내 속붕해 필름형성 조성물 및 ｐｄｅ５ 저해제가 함유된 구강내 속붕해 필름제제 |
| SG10201709195TA (en) | 2012-11-13 | 2017-12-28 | Nusirt Sciences Inc | Compositions and methods for increasing energy metabolism |
| TN2017000029A1 (en) * | 2014-08-12 | 2018-07-04 | Mezzion Pharma Co Ltd | Methods of improving myocardial performance in fontan patients using udenafil compositions |
-
2020
- 2020-05-12 AU AU2020356193A patent/AU2020356193A1/en active Pending
- 2020-05-12 CA CA3155861A patent/CA3155861A1/en active Pending
- 2020-05-12 JP JP2022519057A patent/JP2022550734A/ja active Pending
- 2020-05-12 EP EP20869034.7A patent/EP4041242A4/en active Pending
- 2020-05-12 MX MX2022003593A patent/MX2022003593A/es unknown
- 2020-05-12 WO PCT/US2020/032493 patent/WO2021061203A1/en not_active Ceased
- 2020-07-24 US US16/938,642 patent/US12576081B2/en active Active
-
2025
- 2025-04-08 JP JP2025063654A patent/JP2025118624A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5827893A (en) | Mechanical and pharmacological therapies to treat cardiac arrest | |
| CN102056603A (zh) | 决奈达隆用于预防持续性心房纤颤 | |
| Chua et al. | Novel use of sildenafil in the treatment of portopulmonary hypertension | |
| JP2023540485A5 (https=) | ||
| JP2023116697A5 (https=) | ||
| Varon et al. | Cardiopulmonary resuscitation: a review for clinicians | |
| JP2022550734A5 (https=) | ||
| CN102149377A (zh) | 决奈达隆在制备用于预防中风或短暂性缺血发作的药物中的用途 | |
| COHEN et al. | Adverse hemodynamic effects of phentolamine in primary pulmonary hypertension | |
| JPS63141934A (ja) | ディルチアゼムおよびアンギオテンシン変換酵素阻害剤を含有する医薬組成物 | |
| Galland et al. | Swift recovery of severe hypoxemic pneumonia upon morbid obesity | |
| JP2011522875A (ja) | 電気的除細動を予防するためのドロネダロン | |
| Shocket et al. | Successful open cardiac massage after 75 minutes of closed massage | |
| Giacomini et al. | Vardenafil and weaning from inhaled nitric oxide: effect on pulmonary hypertension in ARDS | |
| CA3155861A1 (en) | Methods of improving exercise performance, single ventricular performance, and myocardial performance index (mpi) in single ventricle heart disease, using udenafil compositions | |
| Sinatra | Refractory congestive heart failure successfully managed with high dose coenzyme Q10 administration | |
| Mason et al. | Combined use of hexamethonium bromide and procaine amide in controlled hypotension | |
| RU2245147C2 (ru) | Применение ингибитора вазопептидазы для лечения стенокардии | |
| JP2004511433A (ja) | 末梢血管疾患、末梢ニューロパシー、及び自律性ニューロパシーの処置方法 | |
| EK et al. | Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure | |
| US20040176387A1 (en) | Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies | |
| JP2025504706A5 (https=) | ||
| Evans et al. | The effects of long term methyldopa in patients with hypoxic cor pulmonale | |
| Galea et al. | Sildenafil in acute pulmonary embolism: case report and review of literature | |
| Hsu et al. | Intrapericardial spontaneous contrast echoes in pneumopyopericardium due to a gas-forming organism |